LEAP-012 TRIAL IN PROGRESS: PEMBROLIZUMAB, LENVATINIB, AND TRANSARTERIAL CHEMOEMBOLIZATION COMBINATION THERAPY FOR INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA NOT AMENABLE TO CURATIVE TREATMENT

被引：0
|
作者：
Vogel, Arndt [1 ]
Llovet, Josep M. [2 ]
El-Khoueiry, Anthony B. [3 ]
Madoff, David C. [4 ,5 ]
Finn, Richard [6 ]
Ogasawara, Sadahisa [7 ]
Ren, Zhenggang [8 ]
Mody, Kalgi [9 ]
Li, Jerry J. [10 ]
Siegel, Abby B. [10 ]
Dubrovsky, Leonid [10 ]
Kudo, Masatoshi [11 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[4] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[5] Yale New Haven Hlth, Smilow Canc Hosp, New Haven, CT USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[7] Chiba Univ, Grad Sch Med, Chiba, Japan
[8] Fudan Univ, Zhongshan Hosp, Dept Hepat Oncol, Shanghai, Peoples R China
[9] Eisai Inc, Woodcliff Lake, NJ USA
[10] Merck & Co Inc, Kenilworth, NJ USA
[11] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Higashiosaka, Osaka, Japan
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1156
引用
收藏
页码：697A / 698A
页数：2
相关论文
共 50 条
  • [41] Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma
    Hung, Ya-Wen
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Rheun-Chuan
    Liu, Chien-An
    Chiu, Nai-Chi
    Hwang, Hsuen-En
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    LIVER CANCER, 2024, 13 (01) : 29 - 40
  • [42] Post progression survival in patients with intermediate-stage hepatocellular carcinoma after receiving transarterial chemoembolization
    Shima, Yukiko
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kobayashi, Kazufumi
    Maruta, Susumu
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maeda, Takahiro
    Kusakabe, Yuko
    Kiyono, Soichiro
    Nakamura, Masato
    Saito, Tomoko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E75 - E75
  • [43] Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study
    Xiang, Cailing
    Shen, Xianbo
    Zeng, Xinxin
    Zhang, Yuzhong
    Ma, Zhongzhi
    Zhang, Guocan
    Song, Xin
    Huang, Tao
    Yang, Juan
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (01) : 315 - 323
  • [44] Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate-stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
    Zheng, Yitao
    Xiang, Yanjun
    Shi, Hongqi
    Lin, Zhuoqun
    Cheng, Shuqun
    Zhu, Jiuting
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1079 - 1093
  • [45] Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate-stage hepatocellular carcinoma: A pilot study
    Huo, Haoran
    Wang, Xiaoying
    Xu, Shan
    Niu, Xiaotong
    Cheng, Limin
    Yuan, Zengjiang
    Huo, Shuang
    Fang, Pingping
    ONCOLOGY LETTERS, 2023, 26 (05)
  • [46] Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
    Dan-Dan Wang
    Jin-Feng Zhang
    Lin-Han Zhang
    Meng Niu
    Hui-Jie Jiang
    Fu-Cang Jia
    Shi-Ting Feng
    Hepatobiliary&PancreaticDiseasesInternational, 2023, 22 (06) : 594 - 604
  • [47] Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
    Wang, Dan-Dan
    Zhang, Jin-Feng
    Zhang, Lin-Han
    Niu, Meng
    Jiang, Hui-Jie
    Jia, Fu-Cang
    Feng, Shi-Ting
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (06) : 594 - 604
  • [48] Efficacy of local-regional treatment plus sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
    Hong, Tzu-Chun
    Tsai, Hong-Ming
    Lin, Yih-Jyh
    Chen, Chiung-Yu
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Chang, Ting-Tsung
    Han, Meng-Zhi
    Lin, Sheng-Hsiang
    Chen, Shang-Hung
    Wang, Hao-Chen
    Chen, Po-Jun
    Hsieh, Ming-Tsung
    Chiang, Hsueh-Chien
    Liu, Chieh-Yen
    Kuo, Hsin-Yu
    ADVANCES IN DIGESTIVE MEDICINE, 2023, 10 (02) : 71 - 79
  • [49] New treatment strategy for intermediate-stage hepatocellular carcinoma: combination of local and systemic therapy
    Tsuchiya, K.
    Yasui, Y.
    Tamaki, N.
    Nakanishi, H.
    Kurosaki, M.
    Izumi, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S1297 - S1297
  • [50] Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib
    Promsorn, Panuwat
    Yamaguchi, Takashi
    Kosaka, Hisashi
    Aoi, Kazunori
    Yoshida, Katsunori
    Matsushima, Hideyuki
    Matsui, Kosuke
    Shimoda, Shinji
    Kaibori, Masaki
    Naganuma, Makoto
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 21 (03)
12345